Immune and Interferon Status in Newborns after Viferon Treatment of Pregnant Women with Cytomegalovirus and Herpes Infection.

Interferon status, cell-mediated and humoral immunity were analyzed in 52 newborns during the first day of life, who were born from mothers infected with cytomegalovirus and herpes simplex virus and treated with viferon in the complex therapy. Comparative group included 44 newborns from mothers with the same infections, who did not receive viferon in the complex therapy. IFN status before delivery as well as parameters of immunity in pregnant women before and after viferon therapy were investigated.